Understanding Dexmedetomidine in Neonates After Open Heart Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Tetrology of FallotHeart VentricleHypoplastic Left Heart
Interventions
DRUG

Dexmedetomidine

Dosage Level 1=0.25mcg/kg loading dose, 0.2 mcg/kg/hr infusion Dosage Level 1A= 0.35mcg/kg loading dose, 0.3 mcg/kg/hr infusion Dosage Level 2= 0.5mcg/kg loading dose, 0.4 mcg/kg/hr infusion

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Athena Zuppa

OTHER

NCT00576381 - Understanding Dexmedetomidine in Neonates After Open Heart Surgery | Biotech Hunter | Biotech Hunter